mHealth Intelligence October 15, 2020
Eric Wicklund

Yale University’s Clinical and Translational Research Accelerator is launching a 6-month study on the value of three different connected health platforms for managing patients living with heart failure.

Researchers at Yale University are launching a connected health study that will analyze three different telehealth and mHealth platforms for treating patients living with heart failure.

The Yale School of Medicine’s Clinical and Translational Research Accelerator (CTRA) is partnering with pharma company Boehringer Ingelheim on the study, which will use the Bodyport smart scale with enhanced cardiac monitoring, Noom’s personalized mHealth coaching app and a chatbot platform developed by Conversa.

“Our digital health study … will move beyond evaluating if these tools work and establish if they actually help make patients’ lives...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, mHealth, Patient / Consumer, Provider, Survey / Study, Technology, Telehealth, Trends
Amwell sells psychiatric telehealth business for $21M
Medicare and telehealth: more restrictive rules could hit patients in 2025
ONRAD acquires teleradiology biz from Philips
Remote Patient Monitoring: Transforming Care Delivery in the New Digital Era 
Lawmakers extend telemedicine coverage expansion through March 31

Share This Article